Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
JACC. Cardiooncology
|
August 21, 2025
Current Insights in Bidirectional Cardio-Oncology: Heart Failure Driving Cancer: JACC: CardioOncology Short-Form Primer
Rudolf A de Boer, Laura I Yousif, Joseph Pierre Aboumsallem, et al.
Current Heart Failure Reports
|
April 7, 2026
TIM-3 in Cardiovascular Disease
Laura I Yousif, Aukje G Sijtema, Margot J Chevalier, et al.
Frontiers in Pharmacology
|
October 20, 2022
The role of immune checkpoints in cardiovascular disease
Laura I Yousif, Anniek A Tanja, Rudolf A de Boer, et al.
Heart, Lung & Circulation
|
February 12, 2025
Cardiotoxicity Beyond Cardiomyocytes-Focus on the Role of Cardiac Fibroblasts and Endothelial Cells
Ymke Appels, Laura I Yousif, Charlotte S Pieters, et al.
Current Oncology Reports
|
April 20, 2023
Risk Factors for Immune Checkpoint Inhibitor-Mediated Cardiovascular Toxicities
Laura I Yousif, Elles M Screever, Daniëlle Versluis, et al.
JACC. Basic to Translational Science
|
April 19, 2026
PD-1/PD-L1 Signaling in Non-ICI Myocarditis
Laura I Yousif, Aukje G Sijtema, Ymke Appels, et al.
JACC. Cardiooncology
|
August 24, 2023
Fibrotic Marker Galectin-3 Identifies Males at Risk of Developing Cancer and Heart Failure
Pieter F van den Berg, Joseph Pierre Aboumsallem, Elles M Screever, et al.
British Journal of Pharmacology
|
November 10, 2022
Characterization of immune checkpoint inhibitor-induced cardiotoxicity reveals interleukin-17A as a driver of cardiac dysfunction after anti-PD-1 treatment
Tamás G Gergely, Dániel Kucsera, Viktória E Tóth, et al.
European Journal of Preventive Cardiology
|
September 27, 2025
Framingham risk score associates with incident cancer and heart failure
Pieter F van den Berg, Laura I Yousif, Yvonne Koop, et al.
NPJ Cardiovascular Health
|
September 22, 2025
The immune checkpoint TIM-3/HMGB-1 axis in myocardial infarction
Laura I Yousif, Aukje G Sijtema, Ymke Appels, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
JACC. Cardiooncology
|
August 21, 2025
Current Insights in Bidirectional Cardio-Oncology: Heart Failure Driving Cancer: JACC: CardioOncology Short-Form Primer
Rudolf A de Boer, Laura I Yousif, Joseph Pierre Aboumsallem, et al.
Current Heart Failure Reports
|
April 7, 2026
TIM-3 in Cardiovascular Disease
Laura I Yousif, Aukje G Sijtema, Margot J Chevalier, et al.
Frontiers in Pharmacology
|
October 20, 2022
The role of immune checkpoints in cardiovascular disease
Laura I Yousif, Anniek A Tanja, Rudolf A de Boer, et al.
Heart, Lung & Circulation
|
February 12, 2025
Cardiotoxicity Beyond Cardiomyocytes-Focus on the Role of Cardiac Fibroblasts and Endothelial Cells
Ymke Appels, Laura I Yousif, Charlotte S Pieters, et al.
Current Oncology Reports
|
April 20, 2023
Risk Factors for Immune Checkpoint Inhibitor-Mediated Cardiovascular Toxicities
Laura I Yousif, Elles M Screever, Daniëlle Versluis, et al.
JACC. Basic to Translational Science
|
April 19, 2026
PD-1/PD-L1 Signaling in Non-ICI Myocarditis
Laura I Yousif, Aukje G Sijtema, Ymke Appels, et al.
JACC. Cardiooncology
|
August 24, 2023
Fibrotic Marker Galectin-3 Identifies Males at Risk of Developing Cancer and Heart Failure
Pieter F van den Berg, Joseph Pierre Aboumsallem, Elles M Screever, et al.
British Journal of Pharmacology
|
November 10, 2022
Characterization of immune checkpoint inhibitor-induced cardiotoxicity reveals interleukin-17A as a driver of cardiac dysfunction after anti-PD-1 treatment
Tamás G Gergely, Dániel Kucsera, Viktória E Tóth, et al.
European Journal of Preventive Cardiology
|
September 27, 2025
Framingham risk score associates with incident cancer and heart failure
Pieter F van den Berg, Laura I Yousif, Yvonne Koop, et al.
NPJ Cardiovascular Health
|
September 22, 2025
The immune checkpoint TIM-3/HMGB-1 axis in myocardial infarction
Laura I Yousif, Aukje G Sijtema, Ymke Appels, et al.
Page
of 2